Diamond Biofund Inc.

NT$14.35As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6901Financials
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR (34.16%)
Div yield —
ROE 26.97%
Asset Management
Beta (5Y) 0.90
PE TTM 4.235
TSR TTM (21.15%)
Mkt cap NT$12.25B
ROIC 55.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$17
21.49%
(37.95%)
Hold 12|2|9|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.14
0.14
0.14
0.15
(4.46%)
(10.16%)
(3.83%)
4.22%
RevenueNT$M
753.3
735.1
758.3
797.2
12.38%
6.24%
6.79%
6.09%
Peers (US$369.9M)
Cap (US$)
PE
455.9M
8.328x
Capital
TTM
5Y
10Y
Leveragex
1.214
0.028
0.036
EBIT/Intx
1.313
0.109
0.116
Own earn%
(3.15)
68.05
71.59
Sh yield%
42.51
23.18
26.49
Owners
Insiders/Inst%
10.48
73.22
Short interest%
5.93
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
19–25
$1 testx
0.0
Incr. ROIC%
3